Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Bristow Group
VTOL
$1.37B
| $17.9M | ﹤0.01% |
382,298
-6,998
| -2% | -$307K |
|
1802
Navient
NAVI
$809M
| $17.9M | ﹤0.01% |
2,189,204
-295,538
| -12% | -$2.93M |
|
1803
J&J Snack Foods
JJSF
$1.46B
| $17.8M | ﹤0.01% |
225,026
+7,862
| +4% | +$680K |
|
|
ARR
1804
Armour Residential REIT
ARR
$2.01B
| $17.8M | ﹤0.01% |
1,068,291
-8,691
| -0.8% | -$154K |
|
1805
Methanex
MEOH
$4.19B
| $17.7M | ﹤0.01% |
298,795
+9,846
| +3% | +$495K |
|
1806
Rayonier Advanced Materials
RYAM
$573M
| $17.7M | ﹤0.01% |
1,600,556
-87,393
| -5% | -$788K |
|
|
XXI
1807
Twenty One Capital Inc
XXI
$1.57B
| $17.7M | ﹤0.01% |
+2,767,605
| New | +$20.3M |
|
|
NBIS
1808
Nebius Group N.V.
NBIS
$47.7B
| $17.7M | ﹤0.01% |
170,248
+10,796
| +7% | +$1.08M |
|
1809
Check Point Software Technologies
CHKP
$13.6B
| $17.7M | ﹤0.01% |
123,608
+15,997
| +15% | +$2.68M |
|
1810
Vanguard Total International Bond ETF
BNDX
$82.2B
| $17.6M | ﹤0.01% |
366,298
-12,652
| -3% | -$613K |
|
1811
Gibraltar Industries
ROCK
$1.36B
| $17.6M | ﹤0.01% |
440,483
+50
| +0% | +$2.42K |
|
1812
Tango Therapeutics
TNGX
$4.35B
| $17.5M | ﹤0.01% |
838,675
-2,317
| -0.3% | -$32.3K |
|
1813
Amprius Technologies
AMPX
$1.38B
| $17.5M | ﹤0.01% |
1,039,394
+2,503
| +0.2% | +$32.6K |
|
1814
Scansource
SCSC
$1.13B
| $17.4M | ﹤0.01% |
480,087
-57,934
| -11% | -$2.21M |
|
1815
Blue Bird Corp
BLBD
$2.41B
| $17.4M | ﹤0.01% |
306,777
+19,214
| +7% | +$1.04M |
|
1816
Simply Good Foods
SMPL
$943M
| $17.4M | ﹤0.01% |
1,211,879
+46,291
| +4% | +$799K |
|
1817
TriMas Corp
TRS
$1.45B
| $17.4M | ﹤0.01% |
483,841
-13,985
| -3% | -$502K |
|
1818
Triumph Financial Inc
TFIN
$1.8B
| $17.4M | ﹤0.01% |
291,208
+1,781
| +0.6% | +$111K |
|
1819
Smith & Wesson
SWBI
$666M
| $17.3M | ﹤0.01% |
1,207,794
-103,709
| -8% | -$1.26M |
|
1820
Celldex Therapeutics
CLDX
$2.8B
| $17.3M | ﹤0.01% |
545,486
-5,243
| -1% | -$143K |
|
1821
Unilever
UL
$132B
| $17.3M | ﹤0.01% |
303,034
+42,577
| +16% | +$2.85M |
|
1822
Scorpio Tankers
STNG
$3.9B
| $17.2M | ﹤0.01% |
230,825
+83,738
| +57% | +$5.61M |
|
1823
Warby Parker
WRBY
$3.05B
| $17.2M | ﹤0.01% |
817,468
-9,595
| -1% | -$238K |
|
1824
Klaviyo
KVYO
$5.31B
| $17.2M | ﹤0.01% |
884,788
+75,359
| +9% | +$1.62M |
|
1825
Sarepta Therapeutics
SRPT
$1.68B
| $17.2M | ﹤0.01% |
791,129
+25,746
| +3% | +$498K |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.